2nd Annual Biomarkers Congress

Biomarkers 2019

Theme: Biomarkers: a new era of detection and clinical exploration

Biomarkers Congress 2019 welcomes all the participants from all across the globe to attend the “ 2nd Annual Biomarkers Congress” which is slated on December 06-07, 2019 at Berlin, Germany with the theme ''Biomarkers: a new era of detection and clinical exploration''. The key vital goal of Meetings International is to impart science and medicinal research amongst the academic/scholarly community, and industry. Biomarkers in the hands of the clinical inspector offers a powerful and effective approach in understanding the opportunity of diseases with distinct applications in analytic epidemiology, biomarkers and clinical research in disease prevention, detection and disease management. Biomarkers have the possible supplementary to find each susceptible to particular diseases. This conference is a platform that brings and shares collective ideas, knowledge and research survey in biomarkers study. In the recent years, the statistics about cancer biomarkers has expanded a massive potential in upgrading the administration of cancer patients by boosting the precision of diagnosis and efficiency in the treatment. Recent technological improvement has a license that the investigation of many viable biomarkers recommende interest in advancing the new biomarkers. All such developments can be exhibited in this biomarker congress.

World Biomarkers 2019 conference will be organized by Meetings International which is comprised of 3000+ international Events with over 2000+ Conferences, 1200+ Symposiums and Workshops on multiple fields of clinical, medical, Pharmaceutical, Engineering, Science, Technology, and Business.

Why To Attend?

This is the best opportunity to reach the largest mass of participants from the Biomarkers and its associated areas. Conduct presentations, distribute statistics, meet with current and potential scientists, construct a dashing with new Development of Biomarkers, and receive name identification at this 2-day event. World-renowned speakers, the most recent techniques, evolution, and the recent updates in Biomarkers are hallmarks of this conference.

Target Audience: 

· Biomarker Research Students and Scientists

· Biomarker Researchers

· Cancer and other Diseases Researchers

· Medical Colleges & Pharmacology Professionals

· Biomarker Associations and Societies

· Bio pharmacists, Biochemist, and Biotech Professionals

· Manufacturing Biomarkers Instruments Companies

· Research and Diagnostic Laboratories and Companies

· Data Management Companies

· Pharmaceutical Companies

· Business Entrepreneurs

 

Session 1: Biomarker and Digital biomarker

Biomarker is a naturally occurring molecule or measurable indicator which is used as an indicator to any particular disease or pathological or physiological state or process of an organism. The physiological or pathological data when collected by means of digital devices such as wearable, portables or implantable is called Digital biomarkers. The data collected is used to explain or predict the health related issues.

Biomarker | Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers | Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

Session 2: Biomarkers in Drug discovery and development

This biomarker conference throws light on the use of biomarkers in drug development which has emphasised the use of biomarkers as surrogate end points for effectiveness. Biomarkers enhances understanding of the mechanism of action, enables the assessment of target engagement, facilitates early proof of dose focusing and increases the efficiency of early clinical development with improved quality of decision making these concepts help in the drug discovery and development process.

Biomarker Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

This clinical conference focuses on biomarkers incorporating in the gene level into earlier stages of the clinical trials which help to separate the patients and help in the development of the biomarker and in case of clinical development this incorporation serves in multiple ways from guiding dose selection to selecting the mode of action to providing the strategy to know about to whom the a particular biomarker can be used.

Biomarker Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

This biomarker conference also concentrates on the cancer biomarker which refers to a substance or a molecule that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumour or a specific response of the body to the presence of cancer. There are different types of cancer where biomarkers have their application such as lung, melanoma, breast, colorectal, pancreas and many more. Cancer biomarkers can be DNA, mRNA, proteins, metabolites, or processes such as apoptosis, angiogenesis or proliferation. The greatest development in the biomarker is the Next Generation Sequencing and the biomarker technology led to the transformation from disease management to healthcare management like the early detection of chronic disease like cancer has increased the chances of survival and also helps to improve the life of thousands of patients around the world.

Biomarker Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

The biomarker congress focuses on the biomarker validation which is an open-ended process with open-ended evidentiary standards, where every potential application of the biomarker needs to be supported by independent studies and datasets. One aspect that has created a revolution in the concept of biomarker research and development is the Next Generation Sequencing which is versatile analysis tool for medical and biological research. Next Generation Sequencing technology refers to one high-throughput DNA sequencing method. In a single experiment, it can determine the sequence of the target gene or full genome with a total size of larger than millions of base pairs. Sequencing thousands of genes or even genomes in one experiment is consequently made possible using this NGS technology.

Biomarker Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

This clinical conference also concentrates on Cardiac markers which are the biomarkers measured to evaluate the heart function. They can be useful in the early prediction or diagnosis of heart disease. Cardiac markers are used in the diagnosis of patients with chest pain and suspected acute coronary syndrome (ACS). The cardiac troponins, in particular, have become the cardiac markers of choice for patients with ACS. Proteomics for cancer biomarker, Clinical proteomic biomarkers, Biomarker discovery and validation in clinical proteomics.

Biomarker Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

This biomarker congress even focuses on the precision medicine biomarkers, which generally refer to a measurable indicator of some biological state or condition. This word refers to a substance, the presence of which indicates the existence of a living organism. Biomarkers used in precision medicine are categorised typically. Autoimmune diseases are a group of diverse diseases with a common etiology in which the immune system responds to self-antigens leading to damage or dysfunction of tissues. Epigenetics act as biomarkers in autoimmune diseases.

Biomarker Digital Biomarkers | Clinical Conference | Biomarker Congress | Cancer Biomarkers | Cardiac Biomarkers | Proteomics | Precision Medicine | Biomarkers Validation | Genomic Biomarkers Biomarkers Meeting

Related Conferences: International Conference on Clinical Research & Biomarkers, June 03-05, 2019, London, UK; 2nd Annual Digital Biomarkers: Biosensors, Wearables, and mHealth, June 19-20, 2019, Boston, MA; 13th Biomarkers and Clinical Research Conference August 22-23, 2019, Vienna, Austria: 3rd Congress on Clinical Science & Biomarkers, September 16-17, 2019, Miami, USA; 4th Cancer Biomarkers Conference, October 05-06, 2019, MS, USA; 15th Annual Biomarkers Congress, February 2020, Manchester, UK

Global Biomarkers Market:

The global market for biomarkers is gaining attraction from a number of factors like increasing diagnosis applications for companion diagnostics and personalized medicine, high prevalence of cancer, increasing investment on research and development by biotechnology and pharmaceutical companies, and new initiatives regarding biomarker research. The entry of new players is expected to further boost the growth of the market. The global biomarkers market size was valued at USD 40.8 billion in 2018 and is expected grow at the rate of 14.2% over the forecast period. Technological advancements led to the development of biomarker-based diagnostics and contribute to the expansion of the market.

Europe Biomarkers Market:-

The Europe Biomarker Market is expected to reach USD 21,478.87 million by 2024, from USD 6,910.58 million in 2016 which is growing at the rate of 15.3% in the forecast period of 2017 to 2024. Europe biomarker market is growing with the increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market.

Diagnostic biomarker market is growing with development of technologies in clinical laboratory tests, imaging exams, and in recent years biomarker tests are impacting the clinical management of patients.

BIOMARKERS MARKET KEY SEGMENTS:-

BY TYPES:-

  • Biomarker of Exposure
  • Biomarker of Diseases

BY APPLICATIONS:-

  • Risk Assessment
  • Development of Molecular Diagnostic
  • Disease Diagnosis
  • Drug Discovery and Development
  • Drug Formulation
  • Forensic Application
  • Others (DNA Fingerprinting and Others)

BY SERVICES:-

  • Sample Preparation
  • Assay Development
  • Biomarker Validation and Testing
  • Other Services

 BY GEOGRAPHY:-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

 In the coming years, North America is expected to register the fastest growth in the market due to the growing acceptance of advanced technologies, entry of new players, new product launches, and wider usage of biomarkers. 

 References:-

  • Biomarker and Digital biomarker
  • Biomarkers in Drug discovery and development
  • Genomic Biomarkers in clinical development and clinical trials
  • Biomarkers in Oncology and developments in biomarkers
  • Biomarkers Validation and Next-Generation sequencing
  • Cardiac biomarkers and Proteomics use in biomarkers
  • Biomarkers for precision medicine and autoimmune disease

2 Organizing Committee Members